NUVL.NASDAQNuvalent, INC

Form 4: Nuvalent Director Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Nuvalent Inc. Director Matthew Shair sold 7,500 shares of Class A Common Stock for approximately $824,130 through a pre-arranged trading plan.

Summary

  • Matthew Shair, a Director of Nuvalent, Inc. (NUVL), reported the sale of 7,500 shares of Class A Common Stock.
  • The transactions occurred on November 24, 2025.
  • These sales were executed pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2024.
  • The shares were sold at weighted average prices ranging from $107.70 to $110.42 per share, with the overall price range for individual transactions being $107.01 to $110.64.
  • The estimated total proceeds from these sales amount to approximately $824,130.
  • Following these transactions, Matthew Shair directly holds 1,377,194 shares and indirectly holds 201,672 shares through the Matthew D. Shair 2021 Irrevocable Family Trust.

Sentiment

Score: 5

Explanation: Neutral. The sale of shares by a director is generally viewed with slight caution, but the execution under a pre-arranged 10b5-1 plan mitigates concerns about immediate negative implications for the company's prospects. It's a routine insider liquidity event.

Positives

  • The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new negative company information.
  • The stock was sold at prices ranging from $107.01 to $110.64, reflecting a relatively strong stock performance at the time of the transactions.

Negatives

  • A director selling a significant number of shares, even under a 10b5-1 plan, can sometimes be perceived with slight caution by the market as it reduces insider ownership.

Future Outlook

NA

Industry Context

This filing reports an insider transaction, which typically reflects personal financial planning decisions of the individual rather than broader industry trends or competitive positioning. The execution under a Rule 10b5-1 plan further supports this interpretation.

Related Party Transactions

  • Matthew D. Shair 2021 Irrevocable Family Trust is considered a related party, through which 1,650 shares were indirectly sold. The reporting person has voting and dispositive power over these shares.

Stakeholder Impact

  • Shareholders: May observe a slight decrease in insider ownership, though the 10b5-1 plan context suggests a planned liquidity event rather than a lack of confidence in the company's future.
  • Employees: No direct impact indicated.
  • Customers: No direct impact indicated.
  • Suppliers: No direct impact indicated.
  • Creditors: No direct impact indicated.

Key Dates

DateDescription
2024-11-20Date Rule 10b5-1 trading plan was adopted by the reporting person.
2025-11-24Date of reported stock transactions (sales of Class A Common Stock).
2025-11-26Date the Form 4 was signed by the attorney-in-fact.

Recommendation

hold

The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. This type of transaction is typically for personal financial planning and does not inherently signal a change in the company's fundamentals or future prospects. While a reduction in insider ownership can sometimes be a minor concern, the pre-scheduled nature of the sale mitigates any immediate negative interpretation. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there's no new information to warrant a change in investment thesis.

Keywords

Nuvalent Inc., NUVL, SEC Form 4, Insider Trading, Stock Sale, Director, Matthew Shair, 10b5-1 Plan, Equity Transaction, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.